Posted inMedical Technology
Click Therapeutics cuts staff after commercial deal restructuring
Click Therapeutics is cutting staff just days after announcing a new funding round and taking over commercial work for its…
Posted inBiotechnology
Astellas to close stem cell unit’s Seattle site, with layoffs incoming
Astellas is preparing to close the Seattle site of its stem cell therapy unit, with around 55 employees set to…
Posted inBiotechnology
Takeda terminates mRNA research pact with Japanese drug discovery specialist
Takeda has pulled back from a research collaboration with a fellow Japanese life sciences company, ending work to discover new…
Posted inBiotechnology
Australia’s Kazia pays research institute $1.4M for epigenetic platform, preclinical drug
Kazia Therapeutics is paying $1.4 million upfront to secure a platform for generating epigenetic drugs from an Australian research institute…
Posted inMedical Technology
Stryker makes a buy as Avalon to go private in a spate of medtech M&A deals
Stryker is picking up vascular devices maker Amplitude Vascular Systems while Avanos Medical is being taken private in a spate…
Posted inBiotechnology
Dynamic Surface Polarization Disrupts Acetylene Hydrogenation Scaling
In a groundbreaking breakthrough poised to revolutionize the field of heterogeneous catalysis, researchers have unveiled a new strategy that challenges…
Posted inBiotechnology
Thermodynamically Consistent Machine Learning Models for Gibbs Energy
In a groundbreaking advance at the crossroads of thermodynamics and machine learning, a team of researchers led by Hoffmann, Specht,…
Posted inBiotechnology
Potent Acridone Targets All Malaria Parasite Stages
Groundbreaking Acridone Compound Demonstrates Unprecedented Efficacy Against All Plasmodium Life Stages, Signaling a New Era in Malaria Treatment Malaria, caused…
Posted inBiotechnology
KIST Develops High-Efficiency Carbon Catalyst to Create Eco-Friendly Disinfectants from Waste Wood
In a groundbreaking advancement bridging sustainable chemistry and renewable energy, a collaboration among leading South Korean scientists has yielded a…
Posted inMedical Technology
Alamar Biosciences files for IPO amid opening life sciences funding window
Californian protein sequencing company Alamar Biosciences is seeking an IPO worth up to $159 million amid a growing boom in…